Table 1 Characteristics of the randomized participants
Number of participants, n | 244 | ||
|---|---|---|---|
Mean age (SD), [range], years | 56.3 | (7.0) | [39–70] |
Gender, n (%) | |||
female | 165 | (67.6) | - |
male | 79 | (32.4) | - |
Highest education level completed, n (%) | |||
high school | 40 | (16.4) | - |
college/university | 204 | (83.6) | - |
Smoking behaviour, n (%) | |||
current | 14 | (5.7) | - |
never | 127 | (52.0) | - |
former | 103 | (42.2) | - |
Body mass index, n (%), kg/m2 | |||
underweight (16.5-17.99) | 2 | (0.8) | - |
normal (18–25) | 112 | (45.9) | - |
overweight (25.01–29.99) | 90 | (36.9) | - |
obese (30+) | 40 | (16.4) | - |
Mean blood pressure (SD), [range], mm Hg | |||
systolic | 127.0 | (18.3) | [85–189] |
diastolic | 80.0 | (11.0) | [55–117] |
Mean low-density lipoprotein level (SD), [range], mmol/L | 3.01 | (0.8) | [1.21–5.57] |
Mean high-density lipoprotein level (SD), [range], mmol/L | 1.66 | (0.44) | [.83–3.20] |
Mean apolipoprotein B level (SD), [range], mmol/L | 0.91 | (0.24) | [.32–1.65] |
Mean glycemia level (SD), [range], mmol/L | 5.0 | (0.7) | [3.7–10.2] |
Participants reported risk factors, n (%) | |||
Hypertension | 29 | (11.9) | - |
Diabetes | 5 | (2.0) | - |
Medications, n (%) | |||
Anti-hypertensive medication | 26 | (10.7) | - |
Hypoglycemic medication | 2 | (0.8) | - |